Journal of the American Chemical Society
Article
(400 MHz, CDCl3) δ 9.57 (dd, J = 5.1, 1.5 Hz, 2H, H2), 8.10 (dd, J =
8.3, 1.5 Hz, 2H, H4), 7.54−7.50 (m, 2H, H5) 7.47−7.42 (m, 2H, H7),
7.38 (dd, J = 7.3, 7.0 Hz, 2 H, H6), 7.31 (dd, J = 5.1, 8.3 Hz, 2H, H3)
3.54 (s, 4H, CH2); 13C NMR (101 MHz, CDCl3) δ 153.1 (C9), 151.8
(C10), 147.3 (C8), 137.2 (C4), 128.7 (C5), 127.8 (C6), 127.6 (C7),
123.5 (C2), 121.2 (C3), 30.1 (CH2); LIFDI-MS m/z 567.90 (calcd for
C20H16Cl2N2Pd2 567.88); IR (KBr, cm−1) 3059, 2919, 2283, 1563,
1505, 1385, 1375, 1316, 1056, 825, 787, 762, 676. Anal. Calcd for
C20H16Cl2N2Pd2: C, 42.28; H, 2.84; N, 4.93. Found: C, 41.92; H, 2.65;
N, 4.71.
(CN), 23.0 (CH2), 3.6 (CH3); LIFDl-MS m/z 309.98 [M − NCCH3]
(calcd for C10H8N2O3Pd 309.96); IR (KBr, cm−1) 2924, 2853, 2253,
1732, 1508, 1438, 1384, 1290, 1027, 824, 783, 327.
Mononuclear PdII Complex 7b [Pd(8-MQ)(NO2)(NCCH3)]. Method
A, starting from 4 and AgNO2: Complex 4 (140 mg, 0.25 mmol) and
silver nitrite (91 mg, 0.6 mmol) were suspended in a mixture of
CH2Cl2 and CH3CN (8 mL, 3:1 v/v) and stirred at room temperature
for 24 h. The reaction mixture was filtered, and the filtrate
concentrated in vacuo to afford 7b as a yellow solid in quantitative
yield (235 mg). Method B, starting from 3 and NaNO2: Complex 3
(105 mg, 0.171 mmol) and sodium nitrite (118 mg, 1.710 mmol) were
suspended under argon in distilled CH3CN (5 mL) and stirred at
reflux for 6 h. The reaction mixture was filtered while hot under argon.
Yellow crystals suitable for X-ray diffraction were grown in the filtrate
when cooled. The crystals were isolated by filtration and dried to yield
Mononuclear PdII Complex 5 [Pd(8-MQ) (PPh3)Cl]. A solution of
Pd(8-MQ) (Cl) dimer 4 (290 mg, 0.5 mmol) and PPh3(288 mg, 1.1
mmol) in CH2Cl2 (20 mL) was stirred at room temperature for 15
min under nitrogen. The reaction mixture was filtered through Celite,
and hexane was added to induce precipitation. The product was
collected by filtration and recrystallized from CH2Cl2/hexane to yield
5 as fine yellow crystals in quantitative yield (579 mg): mp 205−209
1
7b in 61% yield (71 mg): mp 239−242 °C; H NMR (400 MHz,
CDCl3) δ 8.53 (dd, J = 5.0, 1.5 Hz, 1H, H2), 8.29 (dd, J = 8.4, 1.5 Hz,
1H, H4), 7.66−7.57 (m, 2H, H5+H7), 7.49 (t, J = 7.6 Hz, 1H, H6),
7.43 (dd, J = 8.4, 5.0 Hz, 1H, H3), 3.94 (s, 2H), 2.01 (s, 3H); 13C
NMR (101 MHz, CDCl3) δ 152.6 (C2), 149.6 (C9), 147.2 (C8),
138.7 (C4), 129.4 (C6), 129.2 (C7), 128.8 (C5), 127.9 (C10), 124.4
(C3), 121.8 (CN), 27.2 (CH2), 2.1 (CH3); LIFDl-MS m/z 589.85
[2M − 2CH3CN] (calcd for C20H16N4O4Pd2 589.93), 389.06 [M −
NO2 + 8-MQ] (calcd for C20H16N2Pd 390.03); IR (KBr, cm−1) 2919,
2849, 1505, 1435, 1374, 1216, 1055, 1018, 818, 778.
1
°C; H NMR (400 MHz, CDCl3) δ 9.79 (m, 1H, H2), 8.27 (dd, J =
8.3, 1.6 Hz, 1H, H4), 7.86−7.77 (m, 6H, Ar−H), 7.58 (d, J = 7.9 Hz,
1H, H5 or H7), 7.52 (ddd, J = 8.3, 5.0, 1.2 Hz, 1H, H3), 7.46−7.39
(m, 9H, Ar−H), 7.39−7.36 (m, 1H, H6), 7.29 (dq, J = 7.2, 1.3 Hz, 1H,
H5 or H7), 2.85 (d, J = 3.8, 2H); 13C NMR (101 MHz, CDCl3) δ
152.2, 150.4, 148.2, 137.9, 135.0 (d, J = 11.9 Hz), 131.6, 131.1, 130.5
(d, J = 2.6 Hz), 129.1, 128.4 (d, J = 10.8 Hz), 127.7, 123.8, 121.6, 33.4;
31P NMR (162 MHz, CDCl3) δ 35.2; LIFDI-MS m/z 545.05 (calcd
for C28H23ClNPPd 545.03). Anal. Calcd for C28H23ClNPPd: C, 61.56;
H, 4.24; N, 2.56. Found: C, 61.70; H, 4.12; N, 2.21.
Mononuclear PdII Complex 8. Method A, starting from 3 and
NaNO3: Complex 3 (31.7 mg, 0.052 mmol) and NaNO3 (4.4 mg,
0.052 mmol) were suspended in glacial acetic acid (5 mL) and heated
at 50 °C for 1 h. The resulting solution was filtered and concentrated
under vacuum. Layering a solution of the previous powder dissolved in
CH2Cl2 by pentane led to cocrystallization of 8 as orange crystals and
9 as green crystals. Method B, starting from Pd(OAc)2 complex and 2:
Pd(OAc)2 (53.9 mg, 0.24 mmol) and 2 (91 mg, 0.48 mmol) were
suspended in distilled CH2Cl2 (5 mL) under argon and mixed at room
temperature for 6 h. The resulting solution was layered by distilled
pentane (15 mL), and the flask was allowed to sit overnight at 4 °C.
The precipitate was filtered and dried under vacuum to afford complex
9 as a green-brown powder. Crystals suitable for X-ray diffraction were
directly obtained by layering a solution of 9 in CH2Cl2 by pentane.
Selected data from a single crystal (from X-ray): 1H NMR (400 MHz,
CDCl3) δ 8.96 (dd, J = 4.2, 1.7 Hz, 2H, H2), 8.18 (dd, J = 8.3, 1.7 Hz,
2H, H4), 7−85−7.75 (m, 4H, H5+H7), 7.55 (dd, J = 8.2, 7.1 Hz, 2H,
H6), 7.44 (dd, J = 8.3, 4.2 Hz, 2H, H3), 5.86 (s, 4H), 2,28 (s, 3H),
2.21 (s, 6H), 1.96 (s, 3H).
Mononuclear PdII Complex 6a [Pd(8-MQ)(NO3)(PPh3)]. A solution
of 5 (250 mg, 0.46 mmol) and silver nitrate (389 mg, 2.29 mmol) in
CH2Cl2 (20 mL) was stirred at room temperature for 24 h. The
reaction mixture was filtered and the filtrate concentrated in vacuo to
yield 6a as a pale yellow solid in quantitative yield (280 mg). Crystals
suitable for X-ray diffraction were grown by layering of a CH2Cl2
1
solution with cyclohexane: mp 180−183 °C; H NMR (400 MHz,
CD2Cl2) δ 8.75−8.71 (m, 1H, H2), 8.39 (dd, J = 8.3, 1.2 Hz, 1H),
7.77−7.64 (m, 3H), 7.55−7.36 (m, 16H), 3.04 (d, J = 4.2 Hz, 2H);
13C NMR (101 MHz, CD2Cl2) δ 151.1, 148.8, 147.7, 138.4, 134.2 (d, J
= 11.9), 133.9 (d, J = 16.0 Hz), 130.9 (d, J = 2.5 Hz), 129.2, 128.8,
128.7 (d, J = 11.0 Hz), 128.0, 124.1, 121.8, 26.8; 31P NMR (162 MHz,
CD2Cl2) δ 33.0; LIFDI-MS m/z 510.04 [M − NO3] (calcd for
C28H23NPPd 510.06); IR (KBr, cm−1) 3054, 1505, 1447, 1384, 1286,
1096, 1021, 825, 786, 751, 696.
Mononuclear PdII Complex 6b [Pd(8-MQ)(NO2)(PPh3)]. A solution
of 5 (250 mg, 0.46 mmol) and silver nitrite (352 mg, 2.29 mmol) in
CH2Cl2 (20 mL) was stirred at room temperature for 24 h. The
reaction mixture was filtered and the filtrate concentrated in vacuo to
yield 6b as a light brown solid in quantitative yield (315 mg). We
noted that complex 6b is sensitive to air and moisture (OPPh3 formed
over time in CDCl3 solutions of 6b): mp 178−180 °C; 1H NMR (400
MHz, CD2Cl2) δ 8.68 (s, 1H), 8.35 (d, J = 8.2 Hz, 1H), 7.77−7.68 (m,
5H), 7.51−7.37 (m, 12H), 7.36−7.30 (m, 1H), 2.72 (s, 2H); 31P
NMR (162 MHz, dry CD2Cl2) δ 32.4; LIFDI-MS m/z 510.03 [M −
NO2] (calcd for C28H23NPPd 510.06); IR (KBr, cm−1) 3055, 2870,
1684, 1569, 1503, 1481, 1431, 1340, 1095, 825, 752, 696. Complex 6b
retained 0.25 equiv of AgCl. Further purification led to its
decomposition (we were unable to obtain a satisfactory 13C NMR
data for 6b). Anal. Calcd for C28H23N2O2PPd·Ag0.25Cl0.25: C, 56.74; H,
3.91; N, 4.73. Found: C, 56.77; H, 3.95; N, 4.68 (average of two runs).
Mononuclear Pd(II) Complex 7a [Pd(8-MQ)(NO3)(NCCH3)].
Complex 4 (140 mg, 0.25 mmol) and silver nitrate (100 mg, 0.6
mmol) were suspended in a mixture of CH2Cl2 and CH3CN (8 mL,
3:1 v/v) and stirred at room temperature for 24 h. The reaction
mixture was filtered and the filtrate concentrated in vacuo to yield 7a
Dinuclear PdII−PdII Complex 9. Method A, starting from 3 and
NaNO3: Complex 3 (115 mg, 0.19 mmol) and NaNO3 (16 mg, 0.19
mmol) were suspended in glacial acetic acid (10 mL) and heated at 80
°C for 3 h. The resulting solution was filtered and concentrated under
vacuum to afford complex 8 as an orange powder in quantitative yield
(134 mg). Method B, starting from Pd(OAc)2 complex and 8-
quinolinecarboxylic acid 10: Pd(OAc)2 (104 mg, 0.46 mmol) and 8-
quinolinecarboxylic acid 10 (80 mg, 0.46 mmol) were suspended in
glacial acetic acid (10 mL) and heated at 110 °C for 1.5 h. The
resulting solution was filtered and poured into cold distilled water (200
mL). The flask was left overnight at 4 °C. The mixture was
concentrated under vacuum to induce precipitation of the product.
The precipitate was filtered and dried under vacuum to afford complex
8 as an orange powder with 68% yield (106 mg). Crystals suitable for
X-ray diffraction were directly obtained from the concentrated solution
of 8 in AcOD (NMR tube): 1H NMR (400 MHz, CDCl3) δ 8.76 (dd,
J = 5.5, 1.6 Hz, 2H, H2), 8.46 (dd, J = 8.2, 1.6 Hz, 2H, H4), 8.01 (dd, J
= 7.4, 1.6 Hz, 2H, H5), 7.86 (dd, J = 8.1, 1.7 Hz, 2H, H7), 7.58 (dd, J
= 8.2, 5.5 Hz, 2H, H3), 7.31 (t, J = 7.7 Hz, 2H, H6), 2.12 (s, 6H,
CH3); 13C NMR (101 MHz, CDCl3) δ 186.2 (CO, Bn), 172.3 (CO,
AcO), 166.8 (C10), 154.6 (C2), 141.8 (C4), 138.1 (C5), 132.8 (C7),
129.6 (C6), 127.4 (C3), 123.8 (C8), 122.0 (C9),24.0 (CH3); LIFDI-
MS m/z 450.93 (calcd for C20H12N2O4Pd1 ([M-Pd-2OAc]) 450.99);
ESI-MS m/z 698.9075 (calcd for C24H18N2O8Pd2 ([M + Na]+)
698.9079; IR (ATR, cm−1) 3399, 3064, 1722, 1563, 1416, 1333, 1304,
769, 697.
1
as a brown solid in quantitative yield (228 mg): mp 139−143 °C; H
NMR (400 MHz, CDCl3) δ 8.64 (dd, J = 5.2, 1.5 Hz, 1H, H2), 8.26
(dd, J = 8.4, 1.5 Hz, 1H, H4), 7.59 (dd, J = 7.8, 1.3 Hz, 1H, H5), 7.53
(dq, J = 7.1, 1.3 Hz, 1H, H7), 7.46 (dd, J = 7.1, 7.8, Hz, 1H, H6), 7.40
(dd, J = 5.2, 8.4 Hz, 1H, H3) 3.69 (s, 2H, CH2), 2.34 (s, 3H, CH3);
13C NMR (101 MHz, CDCl3) δ 152.5 (C2), 149.7 (C9), 146.5 (C8),
138.4 (C4), 129.0 (C6), 128.5 (C7), 128.3 (C5), 124.2 (C3), 121.7
L
J. Am. Chem. Soc. XXXX, XXX, XXX−XXX